Likewise, increased cardiac ketone oxidation rates in mice with a cardiac‐specific overexpression of BDH1 led to improved cardiovascular outcomes (e.g., increased LVEF, decreased cardiac hypertrophy) in response to TAC‐induced heart failure (Uchihashi et al., 2017). This evidence concerns the gene BDH1 and heart failure.